Targeting SGLT2 inhibition in cardiology: what is the profile of benefit?

27 August 2018 (16:05 - 16:10)
Organised by:
Congress Presentation Part of: Targeting SGLT2 in clinical cardiology: discussing the benefits in cardiovascular risk, diabetes & heart failure Risk Factors and Prevention ESC Premium Access ESC Congress 2018

About the speaker

Photo

RWTH University Hospital Aachen, Aachen (Germany)

2 More presentations in this session

Presentation thumbnail
Professor S. Jacob (Villingen, DE) Professor F. Cosentino (Stockholm, SE) Professor N. Marx (Aachen, DE) Professor J. Deanfield (London, GB)

The Event

Event poster

ESC Congress 2018

27 August 2018 16:05 CET